$COHR

Coherent Vs Amphenol: Which Stock Is The Better Buy?

Coherent (COHR) and Amphenol (APH) are both benefiting from AI data center spending. Coherent's Q4 2026 revenue grew 33.7% YoY, with guidance for Q1 2027 at $2.2B-$2.4B. Amphenol's Q3 2026 sales rose 65% YoY to $10.2B. Coherent trades at 51.1x earnings, while Amphenol is at 33.0x. Coherent's free cash flow is negative, whereas Amphenol generates positive cash flow.

Original reporting
Published Nov 2, 2026, 10:22 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 2, 2026, 10:40 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Coherent Vs Amphenol: Which Stock Is The Better Buy? — source image
Decision brief

The 30-second read

$COHRNeutralMed
01

Why it matters

Both companies show strong top‑line growth, but divergent cash‑flow profiles may drive differing short‑term price action.

02

Market read

Provides fresh guidance and performance metrics that can influence investor positioning in AI‑related hardware stocks.

03

What to watch

Amphenol's acquisition pipeline and potential synergies are not fully quantified in the article.

Relevance 6/10Novelty 5/10Timing: ahead of Coherent Q1 2027 earnings release (Nov 2026)

Background

The piece compares two AI‑hardware suppliers, focusing on recent revenue growth, cash flow, and guidance.

Company-level read

Ticker impact

$COHRNeutralMedium confidence
Context

Coherent disclosed fiscal Q1 2027 revenue guidance of $2.2‑$2.4 B and highlighted ongoing cash‑burn and capacity expansion.

Expected impact

likely pressure unless capacity upgrades exceed expectations

Evidence & confidence

Guidance raises revenue but cash flow remains negative; market may discount earnings until Q1 results.

$APHBullishMedium confidence
Context

Amphenol reported Q3 2026 sales of $10.2 B, 65% YoY growth and $5.12 B free cash flow over the trailing twelve months.

Expected impact

potential support as cash flow exceeds expectations

Evidence & confidence

Robust free cash flow and margin expansion suggest continued investor confidence.

Market effects

Highlights divergent cash‑flow dynamics in the AI‑focused photonics and connectivity components sectors.

U.S. tech and industrial investors may adjust exposure to AI‑related hardware suppliers.

Provides a data point for global AI supply‑chain assessments.

Counterpoint

Coherent's capacity expansion could be undervalued; a successful ramp may trigger a breakout.

Key entities

  • Coherent

    Laser and photonics supplier with new Q1 2027 revenue guidance.

  • Amphenol

    Connectivity components maker reporting Q3 2026 sales and free cash flow.

Related articles

$APHLow

Are You Sure You Understand Amphenol Stock's Risk?

Amphenol (APH) reported Q3 2026 sales of $10.2B, up 65% YoY, with 37% organic growth. Stock returned 15.6% over the past year. Historically, APH stock fell 18.3% on average during market shocks, outperforming the S&P 500. Sales reached $33B in the last 12 months, with operating margins at 28.3%. Debt increased to $17.9B, but remains low relative to market value.

$COHRMedAI 8/10

Coherent Soars 6% as Fabrinet’s 51% Revenue Jump Lifts Optics Stocks Ahead of Earnings

Coherent (COHR) shares rose 6% after Fabrinet reported a 51% revenue increase and raised guidance above estimates. Fabrinet's data center revenue grew 78%, aligning with Coherent's guidance. Coherent reports earnings on Nov. 4, with cash flow concerns due to negative free cash flow of $1.0 billion in fiscal 2026. Marvell's $115 billion deal for Lumentum leaves Coherent as a standalone major laser maker.

$MRVLMedAI 8/10

Marvell’s $115B Lumentum Deal Rattles Chips as AI Doubts Grow

Marvell Technology agreed to buy Lumentum Holdings in an all-stock deal valued at $115B, including debt. Marvell shares fell 12.7% and Lumentum dropped 18.6% on the news. The deal, expected to close by 2028, aims to create an AI connectivity leader, with Marvell shareholders owning about two-thirds of the combined company. Both companies' stocks underperformed the implied deal price, reflecting market doubts about the terms and timing.

$COHRMed

COHR Stock Draws Upgrade As Marvell’s $115B Lumentum Deal Highlights ‘Value Of Scarce AI Optics’

Marvell (MRVL) agreed to acquire Lumentum (LITE) in an all-stock deal valued at $115B. Northland upgraded Coherent (COHR) to 'Outperform' with a $280 price target, citing a share pullback and the value of photonics in AI. JPMorgan expects strong optical demand through 2027, lowering COHR's target to $385 but keeping an 'Overweight' rating. COHR is set to report Q1 2027 earnings on November 4, with revenue and EPS guidance provided.